|
2011-07-12 |
MAGINC Study |
CIGB |
Registered |
|
2011-08-10 |
Teravac HIV in chronic HIV-1. |
CIGB |
Registered |
|
2011-05-20 |
HeberproGen Study |
CIGB |
Registered |
|
2011-05-24 |
SOFIA Study |
CIGB |
Registered |
|
2011-05-17 |
Gamma IFN in Idiopathic Pulmonary Fibrosis. |
CIGB |
Registered |
|
2011-05-19 |
InMuMyel I Study |
CIGB |
Registered |
|
2011-05-03 |
GrUVen-I Study |
CIGB |
Registered |
|
2011-05-03 |
EGFpeeling I |
CIGB |
Registered |
|
2011-05-06 |
Efficacy of laparoscopic Nissen -Rossetti fundoplication in the treatment of gastroesophageal reflux disease. |
CNCMA |
Registered |
|
2011-05-16 |
Clinical Trial Heberbiovac HB vaccine Material Reference Batch |
CIGB |
Registered |
|
2011-05-16 |
NASVAC therapeutic vaccine study |
CIGB |
Registered |
|
2011-05-16 |
Heberprovac Study |
CIGB |
Registered |
|
2011-05-16 |
TS-FARMEV Study |
CIGB |
Registered |
|
2011-05-17 |
CERVISEG-300-I Study |
CIGB |
Registered |
|
2011-04-28 |
Alum Phospate Adjuvated QuimiHib® Vaccine Clinical Study. |
CIGB |
Registered |
|
2011-04-29 |
CENTAURO Study |
CIGB |
Registered |
|
2011-04-29 |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 2-4-6 months. |
CIGB |
Registered |
|
2011-04-30 |
NEUVITAL V Study |
CIGB |
Registered |
|
2011-04-30 |
Change in Manufacture Process of Heberbiovac HB vaccine. |
CIGB |
Registered |
|
2011-04-27 |
Reactogenicity and Immunogenicity of the pentavalent vaccine DPT-HB+Hib. Schedule 6-10-14 weeks. |
CIGB |
Registered |
